Best Alternative to CPAP

Best alternative to CPAP depends on the type and severity of your sleep apnea, your anatomy, and the specific reason CPAP therapy is not working for you. According to the American Academy of Sleep Medicine, oral appliance therapy is the most widely recommended first-line alternative for mild to moderate obstructive sleep apnea, while hypoglossal nerve stimulation has emerged as the leading surgical alternative for moderate to severe cases where CPAP has failed. This guide is for adults who have been diagnosed with sleep apnea and are looking for treatments that do not require wearing a mask every night. It covers oral appliances, nerve stimulation devices, airway surgeries, positional therapy, weight management approaches, and emerging treatments. Understanding how each option affects your airway, your Apnea-Hypopnea Index, and your long-term biological aging risk will help you make a confident, informed decision.

Quick Answer

The best alternative to CPAP for obstructive sleep apnea is an oral appliance (mandibular advancement device) for mild to moderate cases, or hypoglossal nerve stimulation (such as the Inspire device) for moderate to severe cases when CPAP therapy has failed. Positional therapy, weight loss, myofunctional therapy, and upper airway surgery are additional options depending on anatomy and severity. The right choice depends on your Apnea-Hypopnea Index, body mass index, airway anatomy, and personal tolerance. Dumbo Health offers a $149 at-home sleep apnea test and biomarker-driven longevity membership to help identify the best treatment path.

Key Takeaways

• Oral appliance therapy using a mandibular advancement device is the most common CPAP alternative for mild to moderate obstructive sleep apnea, reducing AHI by roughly 50% according to published clinical data.
• Hypoglossal nerve stimulation (Inspire Therapy) is FDA-cleared for moderate to severe obstructive sleep apnea and has shown a median 79% reduction in AHI in the STAR trial five-year outcomes.
• No single CPAP alternative works for every patient; the right option depends on AHI severity, BMI, airway anatomy, and the specific reason CPAP was not tolerated.
• Untreated sleep apnea accelerates biological aging by driving chronic inflammation, cardiovascular strain, and metabolic dysfunction, which is why Dumbo Health tracks sleep-longevity biomarkers alongside clinical sleep apnea care.
• Dumbo Health's Core membership at $0.99 a day includes 51 sleep-longevity biomarkers tested twice a year, with no insurance required.
• The at-home sleep apnea test through Dumbo Health costs $149, is FDA-cleared, and typically delivers a physician diagnosis within 48 hours.

Why People Seek Alternatives to CPAP Therapy

CPAP therapy remains the gold-standard treatment for obstructive sleep apnea, but real-world adherence rates tell a different story. Research published through the National Institutes of Health suggests that roughly 30% to 50% of patients prescribed CPAP do not use it consistently, with mask discomfort, mask leaks, nasal congestion, air pressure intolerance, and lifestyle disruption cited as the most common reasons.

CPAP works by delivering continuous positive airway pressure through a mask to keep the airway open during sleep. For many people, the concept is sound but the experience is intolerable. Mask fit problems, claustrophobia, dry mouth, aerophagia, and noise from PAP machines drive patients to remove the device partway through the night or abandon it entirely.

The clinical consequence of CPAP non-adherence is significant. When sleep apnea goes untreated, the repeated airway obstruction and oxygen desaturation events drive systemic inflammation, elevate cortisol, disrupt metabolic markers like HbA1c and hs-CRP, and increase cardiovascular risk. These are the same biomarkers that accelerate biological aging, which is why Dumbo Health frames untreated sleep apnea as a longevity problem, not just a sleep disorder.

Common Reasons CPAP Fails

• Mask discomfort or poor mask fit causing pressure sores and skin irritation
• Mask leaks that reduce therapeutic pressure and wake the patient
• Air pressure intolerance, especially during exhalation
• Nasal congestion, dry mouth, or nasal pillows irritation
• Claustrophobia or anxiety triggered by wearing a mask during sleep
• Noise from the device disrupting sleep for the patient or bed partner
• Travel inconvenience and difficulty maintaining sleep habits on the road
• Social or relationship discomfort

Understanding which of these barriers applies to you is the first step toward identifying the right alternative. A sleep study, whether conducted at a lab or through a home sleep apnea test, establishes your baseline AHI and oxygen desaturation index, which determine which alternatives are clinically appropriate.

DID YOU KNOW: The Wisconsin Sleep Cohort Study found that obstructive sleep apnea affects an estimated 1 in 5 adults when using current diagnostic criteria, and the majority remain undiagnosed.

KEY TAKEAWAY: CPAP non-adherence is extremely common, and untreated sleep apnea accelerates biological aging through inflammation, metabolic disruption, and cardiovascular strain, making it critical to find an effective alternative rather than abandoning treatment entirely.

Knowing why CPAP fails for so many patients sets the stage for evaluating each alternative on its own clinical merits.

Oral Appliance Therapy: The Most Common CPAP Alternative

Oral appliance therapy is the most widely prescribed alternative to CPAP for adults with mild to moderate obstructive sleep apnea. The American Academy of Sleep Medicine recommends it as a first-line treatment when CPAP is not tolerated or when patients prefer a non-machine-based option.

How Mandibular Advancement Devices Work

A mandibular advancement device, or MAD, is a custom-fitted dental device worn in the mouth during sleep. It works by advancing the lower jaw (mandible) forward, which pulls the tongue and soft palate away from the back of the airway. This mandibular advancement increases the diameter of the upper airway, reduces airway obstruction, and decreases snoring and apnea events.

Mandibular advancement devices are the most studied and most commonly used oral appliances for sleep apnea treatment. They are distinct from over-the-counter snoring mouthpieces, which are not FDA-cleared for treating obstructive sleep apnea and lack the precision of a custom-fitted device.

A trained sleep dentist or otolaryngologist takes impressions or digital scans of the teeth and jaw, then fabricates the device to ensure proper fit, bite alignment, and the optimal degree of jaw advancement. The device is adjustable in most modern designs, allowing the clinician to titrate the advancement forward in small increments until the Apnea-Hypopnea Index reaches an acceptable level.

Tongue Retaining Devices

Tongue retaining devices, also called tongue stabilizing devices or TSDs, are a less common type of oral appliance. A tongue-retaining device holds the tongue forward using suction rather than advancing the jaw. These are sometimes used for patients who cannot tolerate mandibular advancement due to dental issues, TMJ problems, or insufficient teeth for a MAD to anchor against.

Tongue retaining devices have less published evidence than mandibular advancement devices, but they remain a viable option in specific clinical scenarios.

Clinical Effectiveness of Oral Appliances

Published research indicates that mandibular advancement devices reduce AHI by approximately 50% on average. For patients with mild obstructive sleep apnea (AHI 5 to 15), oral appliance therapy frequently reduces AHI to below 5, which is considered the normal range. For moderate cases (AHI 15 to 30), MADs often achieve meaningful improvement, though some patients may not reach full normalization.

The American Academy of Sleep Medicine notes that while CPAP is more effective at reducing AHI in controlled studies, oral appliance therapy often achieves comparable real-world health outcomes because patients use it more consistently. Adherence to oral appliances is generally higher than CPAP adherence because the device is simpler, quieter, portable, and does not involve a mask, hose, or air pressure.

Who Is a Good Candidate for Oral Appliance Therapy

• Adults with mild to moderate obstructive sleep apnea (AHI 5 to 30)
• Patients who have tried CPAP and cannot tolerate mask discomfort, mask leaks, or air pressure
• People who travel frequently and need a portable treatment
• Patients who snore heavily but have a relatively low AHI
• Adults with sufficient healthy teeth to anchor the device

Oral appliance therapy is generally less effective for severe obstructive sleep apnea (AHI above 30) and for patients with significant obesity, because the degree of airway obstruction in these cases may exceed what jaw advancement alone can address.

Limitations of Oral Appliances

Oral appliances are not without adverse effects. Common issues include temporomandibular joint discomfort, tooth shifting over years of use, excessive salivation or dry mouth, and bite changes. Regular follow-up with a dental specialist is necessary to monitor these effects. Insurance coverage for custom devices varies widely.

Because oral appliance therapy treats the mechanical obstruction without addressing the systemic damage that prior years of untreated sleep apnea may have caused, tracking inflammation and metabolic biomarkers remains important. Dumbo Health's Core membership includes 51 sleep-longevity biomarkers tested twice a year, giving oral appliance users a way to monitor whether their treatment is reversing the biological aging effects of past airway obstruction.

KEY TAKEAWAY: Oral appliance therapy using a mandibular advancement device is the best-established CPAP alternative for mild to moderate sleep apnea, offering higher real-world adherence than CPAP, though it may not suffice for severe cases or patients with high BMI.

For patients whose sleep apnea is too severe for an oral appliance, hypoglossal nerve stimulation offers a fundamentally different approach.

Hypoglossal Nerve Stimulation: The Surgical Alternative for Moderate to Severe Sleep Apnea

Hypoglossal nerve stimulation is the most significant surgical innovation in sleep apnea treatment in the past decade. It targets the root cause of airway collapse by electrically stimulating the hypoglossal nerve to activate the tongue muscles during sleep, keeping the airway open without external air pressure or a device in the mouth.

How Inspire Therapy Works

The Inspire device, manufactured by Inspire Medical Systems, is the most widely implanted hypoglossal nerve stimulation system. It was cleared by the Food and Drug Administration in 2014 and has since been implanted in over 100,000 patients worldwide.

The system consists of three implanted components: a small generator placed under the skin of the upper chest (similar in size to a cardiac pacemaker), a sensing lead positioned between the intercostal muscles to detect breathing patterns, and a stimulation lead wrapped around the hypoglossal nerve beneath the jaw. When the sensing lead detects an inhalation, the generator sends a mild electrical impulse through the stimulation lead to the hypoglossal nerve, which causes the tongue to move forward and stiffen, preventing it from collapsing into the airway.

Patients control the device with a handheld remote, turning it on before sleep and off upon waking. The stimulation is timed to each breath cycle, so the tongue moves naturally with respiration.

Inspire Therapy Eligibility

The Inspire device is indicated for adults with moderate to severe obstructive sleep apnea who meet specific criteria:

• AHI between 15 and 100 (some centers now consider AHI up to 100 with Inspire V)
• Inability to tolerate or benefit from CPAP therapy
• Body Mass Index at or below 40
• Absence of complete concentric collapse at the soft palate level, confirmed by drug-induced sleep endoscopy

The drug-induced sleep endoscopy, or DISE, is a critical pre-surgical evaluation. During this procedure, a sleep specialist or otolaryngologist administers sedation to simulate natural sleep and uses a flexible camera to observe the pattern of airway collapse. If the collapse is primarily at the tongue base and lateral pharyngeal wall muscles rather than a circumferential collapse of the soft palate, the patient is a good candidate for hypoglossal nerve stimulation.

Clinical Outcomes

The STAR trial, the landmark study for Inspire Therapy, demonstrated a median 68% reduction in AHI at 12 months. At five years, the median AHI reduction was 79%, and 75% of patients achieved an AHI below 15 events per hour. Daytime sleepiness, measured by the Epworth Sleepiness Scale, also improved significantly, and bed partner satisfaction with snoring reduction exceeded 90%.

Other Nerve Stimulation Devices

Inspire is not the only hypoglossal nerve stimulation system available globally. Nyxoah manufactures the Genio system, a smaller, battery-free device that stimulates both hypoglossal nerves bilaterally through an external activation patch worn under the chin during sleep. The Genio system received CE marking in Europe and has been reviewed by the FDA. Its bilateral stimulation approach differs from Inspire's unilateral stimulation.

Both nerve-stimulation devices represent a shift from managing airway pressure to treating the neuromuscular cause of obstruction. The choice between them depends on availability, insurance coverage, and the clinical recommendations of the treating sleep specialist.

Cost and Insurance Considerations

Most commercial insurance plans and Medicare cover Inspire for patients who meet the clinical criteria, though prior authorization is usually required. The approval process can take weeks, and not all patients who clinically qualify receive insurance approval on the first attempt.

By contrast, identifying whether you are even a candidate starts with confirming your current AHI. Dumbo Health offers an FDA-cleared at-home sleep apnea test for $149, with physician diagnosis typically within 48 hours, no insurance required, and no prior authorization. This can serve as the first diagnostic step before pursuing Inspire or any other surgical treatment.

KEY TAKEAWAY: Hypoglossal nerve stimulation, particularly the Inspire device, is the leading surgical CPAP alternative for moderate to severe obstructive sleep apnea, but it requires surgical implantation, specific anatomical eligibility confirmed by drug-induced sleep endoscopy, and is typically reserved for patients who have already failed CPAP.

Beyond implantable devices, several traditional airway surgeries can address the structural causes of obstruction directly.

Upper Airway Surgery for Sleep Apnea

Upper airway surgery is a CPAP alternative for patients whose sleep apnea is caused by identifiable anatomical blockages in the nose, mouth, or throat. Unlike hypoglossal nerve stimulation, airway surgeries physically modify the structures that cause obstruction rather than stimulating muscles to keep them open.

Uvulopalatopharyngoplasty

Uvulopalatopharyngoplasty, commonly known as UPPP, is the most frequently performed sleep surgery. It involves removing or repositioning excess tissue from the soft palate, uvula, and lateral pharyngeal walls to widen the airway behind the mouth. The procedure is performed under general anesthesia, typically as an outpatient surgery, and recovery involves significant throat pain for one to two weeks.

UPPP was developed in the 1980s and remains widely available, but its effectiveness as a standalone treatment for moderate to severe obstructive sleep apnea has been questioned. The American Academy of Sleep Medicine notes that UPPP alone achieves an AHI reduction below 20 in roughly 40% to 50% of patients. Success rates improve when UPPP is combined with other procedures as part of a multilevel surgical approach.

Potential adverse effects of UPPP include velopharyngeal insufficiency (nasal regurgitation of liquids when swallowing), velopharyngeal stenosis (narrowing from scar tissue), changes to voice quality, and persistent dry throat.

Barbed Reposition Pharyngoplasty and Lateral Pharyngoplasty

Newer techniques such as barbed reposition pharyngoplasty and lateral pharyngoplasty have been developed to improve on UPPP's outcomes by repositioning tissue rather than removing it. These approaches aim to expand the lateral airway space while reducing the risk of scarring and velopharyngeal complications. Early published data suggests improved outcomes compared to traditional UPPP, though long-term studies are still accumulating.

Maxillomandibular Advancement

Maxillomandibular advancement is one of the most effective surgical treatments for obstructive sleep apnea. This procedure involves surgically moving both the upper jaw (maxilla) and lower jaw (mandible) forward, which physically enlarges the entire upper airway space behind the tongue and soft palate.

Maxillomandibular advancement, sometimes referred to as mandibular or maxillary advancement, has reported success rates exceeding 85% for reducing AHI below 15 in carefully selected patients. It is typically reserved for patients with severe obstructive sleep apnea who have failed both CPAP and other treatments, or for patients with jaw anatomy (small or recessed jaw bones) that clearly contributes to their airway obstruction.

The surgery requires general anesthesia, an inpatient hospital stay, a recovery period of several weeks, and carries risks including numbness, bite changes, and the need for orthodontic treatment before and after surgery.

Nasal Surgery

Nasal surgery, including septoplasty (correction of a deviated septum), turbinate reduction, and adenoidectomy (removal of enlarged adenoids, more common in children), does not typically cure sleep apnea on its own. However, nasal surgery can improve CPAP tolerance by reducing nasal resistance, and it can enhance the effectiveness of oral appliances and positional therapy by improving nasal airflow.

For patients who struggle with CPAP because of nasal congestion or a deviated septum, nasal surgery may convert them from CPAP-intolerant to CPAP-tolerant, which is sometimes the most practical path forward.

Tonsillectomy

Tonsillectomy, the removal of the palatine tonsils, is highly effective for sleep apnea in children and can be effective for adults with significantly enlarged tonsils. In adults, tonsillectomy is often performed alongside UPPP or other pharyngeal procedures as part of a multilevel surgical plan.

Drug-Induced Sleep Endoscopy as a Surgical Planning Tool

Drug-induced sleep endoscopy has become essential for surgical planning. During sleep endoscopy, the surgeon observes exactly where and how the airway collapses under sedation. This allows the surgical treatments to be targeted to the specific site of obstruction, whether it is the soft palate, tongue base, lateral pharyngeal wall muscles, or epiglottis.

Without sleep endoscopy, surgeons relied on awake examination findings, which often do not match what happens during actual sleep. The adoption of drug-induced sleep endoscopy has improved surgical success rates by enabling personalized surgical planning.

Choosing the Right Surgery

The best upper airway surgery depends on the site and pattern of airway collapse, the severity of the sleep apnea, the patient's BMI, and overall health status. An otolaryngologist or sleep surgeon with expertise in sleep medicine should evaluate each patient individually, often using drug-induced sleep endoscopy, before recommending a specific surgical treatments approach.

DID YOU KNOW: Combining several targeted airway procedures, chosen from what drug-induced sleep endoscopy shows, tends to work better for moderate to severe obstructive sleep apnea than a single procedure on its own.

KEY TAKEAWAY: Upper airway surgery can be an effective CPAP alternative when targeted to the specific anatomical site of obstruction, but no single procedure works for all patients, and drug-induced sleep endoscopy has become the standard tool for personalized surgical planning.

While surgery addresses structural causes, behavioral and lifestyle approaches target the modifiable factors that worsen or cause sleep apnea.

Positional Therapy and Lifestyle Modifications

Positional therapy is a behavioral sleep apnea treatment that works by preventing the patient from sleeping on their back, the position where gravity pulls the tongue and soft palate into the airway most aggressively. For a meaningful subset of patients, sleep position alone determines whether their AHI is clinically significant.

How Positional Sleep Therapy Works

Position-dependent sleep apnea is defined as having an AHI that is at least twice as high when sleeping supine (on the back) compared to sleeping in a lateral (side) position. Studies suggest that roughly 50% to 60% of patients with obstructive sleep apnea have a significant positional component.

Positional therapy devices range from simple approaches like the tennis ball technique, which involves attaching a tennis ball to the back of a sleep shirt to prevent rolling onto the back, to commercially available wearable devices that vibrate when the sleeper shifts to a supine position. Modern positional sleep therapy devices are smaller, quieter, and more effective than the tennis ball technique, and some integrate with smartphone apps to track compliance and sleep position data.

Positional therapy is most effective for mild to moderate positional obstructive sleep apnea. It is generally not sufficient as a standalone treatment for severe cases, where airway obstruction occurs in all positions.

Weight Management and Obesity

Obesity is the single most important modifiable risk factor for obstructive sleep apnea. The relationship between Body Mass Index and AHI is well established. According to the National Heart, Lung, and Blood Institute, a 10% reduction in body weight can reduce AHI by approximately 26% to 30% in overweight and obese patients.

Excess weight contributes to sleep apnea through multiple mechanisms: increased tongue fat, fat deposits in the soft palate and lateral pharyngeal walls, and reduced lung volume that makes the airway more collapsible. Weight loss through diet, exercise, or medical intervention addresses these root causes rather than merely managing symptoms.

Bariatric surgery is the most effective weight loss intervention for patients with severe obesity (BMI above 40, or above 35 with comorbidities). Studies show that bariatric surgery resolves or significantly improves obstructive sleep apnea in over 75% of patients. However, bariatric surgery is a major procedure with its own risks and requirements.

GLP-1 Medications for Weight Loss and Sleep Apnea

A newer development in sleep apnea treatment is the use of glucagon-like peptide 1 receptor agonists, such as tirzepatide (marketed as Zepbound for weight management). In a clinical trial published in 2024, Zepbound demonstrated a mean AHI reduction of approximately 50% in obese patients with moderate to severe obstructive sleep apnea, driven by significant weight loss. The FDA approved Zepbound for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, making it the first medication specifically approved for sleep apnea.

This represents a paradigm shift: for the first time, medications can meaningfully treat sleep apnea by addressing the obesity that causes it. However, GLP-1 receptor agonists require ongoing use to maintain weight loss, can be expensive without insurance, and are not appropriate for non-obese patients with sleep apnea.

Myofunctional Therapy

Myofunctional therapy involves exercises that strengthen the muscles of the tongue, mouth, soft palate, and throat. By improving the tone and coordination of these muscles, myofunctional therapy can reduce the tendency of the airway to collapse during sleep.

A meta-analysis cited by the American Academy of Sleep Medicine found that myofunctional therapy reduced AHI by approximately 50% in adults and 62% in children. It also significantly reduced snoring. Myofunctional therapy is non-invasive, has no adverse effects, and can be used alongside other treatments. Its main limitation is that it requires consistent daily practice over weeks to months to see results, and adherence can be challenging.

Sleep Habits and Sleep Quality

Improving sleep habits alone will not cure obstructive sleep apnea, but poor sleep habits can worsen it. Alcohol before bed relaxes airway muscles and increases the severity and frequency of apnea events. Sedative medications can have a similar effect. Maintaining a consistent sleep schedule supports circadian rhythm stability, which influences sleep architecture and the distribution of sleep stages.

Dumbo Health's sleep longevity membership integrates wearable devices data from Oura, Whoop, and Garmin to track sleep quality patterns alongside blood biomarkers. This combination reveals whether lifestyle modifications are actually moving the needle on both sleep quality and the biomarkers of biological aging.

KEY TAKEAWAY: Positional therapy works well for position-dependent mild to moderate sleep apnea, weight loss is the most impactful lifestyle intervention, and GLP-1 receptor agonists like Zepbound have introduced a pharmaceutical option for obese patients, but none of these approaches replaces medical evaluation and monitoring.

With lifestyle and surgical options covered, several less conventional devices and emerging treatments deserve attention.

EPAP Devices, Nasal Therapies, and Emerging Alternatives

Expiratory positive airway pressure (EPAP) devices are a category of CPAP alternative that creates back-pressure during exhalation to keep the airway open, without requiring the continuous air pressure delivered by PAP machines.

How EPAP Works

EPAP devices use one-way valves placed over or inside the nostrils. Air flows in freely during inhalation, but the valve creates resistance during exhalation, generating positive pressure that splints the airway open. This is similar in concept to CPAP but without a machine, hose, or mask.

Provent Therapy was the most well-known disposable nasal EPAP device. It used adhesive patches placed over each nostril with embedded one-way valves. Clinical trials showed Provent reduced AHI by a meaningful amount in mild to moderate obstructive sleep apnea, though results were less consistent for severe cases. Provent is no longer widely available on the market, but the EPAP concept has been adapted into other devices.

Nasal EPAP represents a broader category that includes various designs using the same exhalation-resistance principle. These devices appeal to patients who want a simple, portable, mask-free option.

Oral Pressure Therapy

Oral pressure therapy, sometimes classified alongside EPAP devices, uses a small device worn in the mouth that creates negative pressure (cNEP, or continuous negative external pressure) to pull the soft palate forward and keep the airway open. This approach targets the velopharyngeal region specifically.

Clinical data on oral pressure therapy is more limited than for mandibular advancement devices, and the devices have not achieved the same level of market adoption or clinical endorsement.

eXciteOSA and Electric Muscle Stimulation Devices

eXciteOSA is an FDA-cleared daytime-use device that delivers electric muscle stimulation to the tongue through a mouthpiece worn for 20 minutes per day while awake. The goal is to improve tongue muscle tone, similar to myofunctional therapy but using electrical stimulation rather than voluntary exercises.

The device targets patients with mild obstructive sleep apnea and snoring. Clinical data showed modest reductions in AHI and significant snoring reduction. Electric muscle stimulation devices represent a non-invasive, non-surgical approach, but they are not appropriate for moderate to severe sleep apnea and require consistent daily use.

BiPAP and APAP as CPAP Modifications

Bilevel positive airway pressure, or BiPAP, delivers two different levels of air pressure: a higher pressure during inhalation and a lower pressure during exhalation. A bilevel positive airway pressure device can be more comfortable for patients who struggle with exhaling against the constant pressure of standard CPAP.

APAP, or auto-adjusting positive airway pressure, automatically varies the pressure throughout the night based on detected events. APAP machines can reduce average pressure exposure compared to fixed CPAP, which may improve comfort and reduce mask leaks.

While BiPAP and APAP are technically still PAP machines, they represent modifications that solve specific comfort problems. For patients whose primary complaint is air pressure intolerance during exhalation, switching from CPAP to BiPAP or APAP may be sufficient to achieve adherence without abandoning the PAP category entirely.

Central sleep apnea, which is caused by the brain failing to signal breathing rather than by physical airway obstruction, requires different treatment than obstructive sleep apnea. Most CPAP alternatives discussed in this article are designed for obstructive sleep apnea and are not appropriate for central sleep apnea without specific medical guidance.

KEY TAKEAWAY: EPAP devices, electric muscle stimulation, and modified PAP machines like BiPAP and APAP offer additional options for patients who cannot tolerate standard CPAP, but most are best suited for mild to moderate cases and have less robust clinical evidence than oral appliances or hypoglossal nerve stimulation.

Understanding all available options is important, but so is understanding what each option cannot do.

Limitations and Risks: When a CPAP Alternative May Not Be the Right Choice

No CPAP alternative is universally effective. Each option carries specific limitations, risks, and situations where it may not work or may even cause harm.

Limitation 1: Severe Obstructive Sleep Apnea May Require CPAP or Surgery

For patients with severe obstructive sleep apnea (AHI above 30), oral appliances, positional therapy, and EPAP devices frequently fail to reduce AHI to a safe level. The American Academy of Sleep Medicine recommends CPAP as first-line therapy for severe cases precisely because alternatives are less likely to achieve adequate control. When a patient with severe sleep apnea cannot tolerate CPAP, hypoglossal nerve stimulation or maxillomandibular advancement surgery may be the only effective alternatives, and both involve significant procedures.

If you have severe sleep apnea and want to avoid CPAP, work with a sleep specialist who can perform drug-induced sleep endoscopy and evaluate you for surgical candidacy rather than defaulting to a less intensive option that may leave dangerous levels of apnea untreated.

Limitation 2: Oral Appliances Can Cause Dental and TMJ Problems Over Time

Long-term use of mandibular advancement devices has been associated with tooth movement, bite changes, and temporomandibular joint pain. Some patients develop an anterior open bite after years of nightly jaw advancement. Regular dental monitoring is necessary, and not every patient can tolerate the device indefinitely.

Limitation 3: Surgical Outcomes Are Not Guaranteed

Upper airway surgery, including uvulopalatopharyngoplasty, has variable success rates. According to published data, UPPP alone achieves meaningful AHI reduction in roughly half of patients. Surgical failure can leave patients with the same sleep apnea plus surgical side effects such as velopharyngeal stenosis, chronic dry throat, or scar tissue that complicates future treatment options.

Hypoglossal nerve stimulation has better published outcomes, but it requires permanent implant maintenance, battery replacement surgery every 10 to 15 years, and carries typical surgical risks including infection and lead migration. The inspire device is not reversible in the sense that components remain implanted even if the device is turned off.

Limitation 4: Weight Loss Takes Time and May Not Fully Resolve Apnea

Even substantial weight loss may not eliminate sleep apnea entirely, particularly in patients with anatomical factors like a narrow airway, large tonsils, or a recessed mandible. While bariatric surgery and medications like Zepbound produce significant weight loss, the AHI may not normalize completely, and patients often still need a secondary treatment.

Limitation 5: Insurance Coverage Is Inconsistent

Insurance coverage for CPAP alternatives varies dramatically. Oral appliances may or may not be covered by medical or dental insurance. Inspire Therapy is increasingly covered by commercial insurance and Medicare, but prior authorization requirements and denials are common. GLP-1 receptor agonists are expensive without coverage and have restrictive formulary placement. Nasal surgeries and UPPP are generally covered but require documented medical necessity.

Dumbo Health helps mitigate the insurance barrier for the diagnostic step. The $149 at-home sleep apnea test requires no insurance, no prior authorization, and no surprise bills. For ongoing longevity monitoring, the Core membership is HSA and FSA eligible, giving members a tax-advantaged way to track whether their chosen treatment is actually working at the biomarker level.

Limitation 6: State Availability for Telehealth Sleep Care

Dumbo Health's at-home sleep apnea test and CPAP care are available only in Florida, Texas, Virginia and Maryland. If you live in another state, a local sleep specialist can order testing and guide treatment.

KEY TAKEAWAY: Every CPAP alternative has specific limitations, and choosing the wrong one for your severity level, anatomy, or health profile can leave dangerous sleep apnea undertreated, so physician evaluation and ongoing monitoring are essential.

Weighing these limitations is easier when you can see how each option applies to real people in real situations.

How to Choose the Right CPAP Alternative: A Personalized Treatment Plan

Choosing the best alternative to CPAP starts with an accurate diagnosis and ends with a personalized treatment plan built around your specific AHI, anatomy, BMI, symptoms, and preferences. Sleep specialists, including board-certified physicians in sleep medicine, can guide this process using clinical data rather than guesswork.

Step-by-Step Process for Finding Your Best CPAP Alternative

1. Get an accurate sleep apnea diagnosis with a current AHI measurement. If you do not have a recent sleep study, order a home sleep apnea test through Dumbo Health for $149, with FDA-cleared testing and physician diagnosis typically within 48 hours.
2. Review your AHI severity. Mild is 5 to 15 events per hour, moderate is 15 to 30, and severe is above 30. Your severity level determines which alternatives are clinically appropriate.
3. Assess your BMI and weight status. If your Body Mass Index is above 30, weight management should be part of any treatment plan. If above 35 or 40 with comorbidities, discuss bariatric surgery or GLP-1 medications with your physician.
4. Consult a sleep specialist to discuss your CPAP history, why CPAP failed, and your preferences. Ask about oral appliance therapy, hypoglossal nerve stimulation eligibility, and positional therapy.
5. If surgery is being considered, request drug-induced sleep endoscopy to identify the specific site and pattern of airway collapse before committing to any procedure.
6. Start baseline biomarker tracking with Dumbo Health's sleep longevity membership to measure how sleep apnea has affected your inflammation, metabolic, and cardiovascular markers, and to track improvement over time.
7. Begin treatment and schedule a follow-up sleep study or home test in 8 to 12 weeks to verify that your chosen alternative is reducing your AHI to an acceptable level.
8. Reassess annually. Treatment needs change with weight, aging, and health status. Ongoing biomarker monitoring through the SleepLongevityAge metric helps detect early signs that treatment effectiveness is declining.

After completing these steps, you will have a data-driven treatment plan tailored to your specific situation rather than a generic recommendation.

Checklist: What to Verify Before Choosing a CPAP Alternative

• Confirm your current AHI from a recent sleep study or home sleep apnea test (within the past 12 months)
• Know your Body Mass Index and whether weight loss is part of your treatment path
• Document why CPAP failed for you (mask discomfort, air pressure intolerance, mask leaks, lifestyle factors)
• Verify whether your sleep apnea is obstructive, central, or mixed, since alternatives differ by type
• Check whether your insurance plan covers the alternative you are considering, or plan for cash-pay costs
• Ask your physician about drug-induced sleep endoscopy if surgery or nerve stimulation is under consideration

• Take the free Dumbo Health quiz to understand your sleep longevity risk profile
• Confirm the follow-up testing plan to verify treatment effectiveness after starting
• Ensure you have a way to track biomarkers over time, not just AHI

Real-World Examples

A 38-year-old marketing executive with mild obstructive sleep apnea (AHI 12) tried CPAP for six months but abandoned it due to mask discomfort and travel inconvenience. Her sleep specialist fitted her with a custom mandibular advancement device. A follow-up home sleep apnea test showed her AHI dropped to 4. She also enrolled in Dumbo Health's Core membership to track whether her hs-CRP and HbA1c markers were improving alongside her reduced apnea.

A 52-year-old construction company owner with severe obstructive sleep apnea (AHI 48) and a BMI of 34 could not tolerate CPAP due to claustrophobia. His otolaryngologist performed drug-induced sleep endoscopy, which showed tongue base collapse without concentric soft palate collapse. He was approved for Inspire hypoglossal nerve stimulation. Post-implant, his AHI decreased to 8, his Epworth Sleepiness Scale score dropped from 15 to 5, and his brain fog resolved. He also began working with his physician on weight loss to further reduce his residual apnea risk.

A 45-year-old nurse with moderate positional obstructive sleep apnea (AHI 22 supine, AHI 6 lateral) used a vibrating positional therapy device that trained her to sleep on her side. Her overall AHI dropped to 7 without any other intervention. She paired this with myofunctional therapy exercises and wore an Oura ring, integrating her wearable data through Dumbo Health to monitor her heart rate variability and sleep architecture trends.

KEY TAKEAWAY: The best CPAP alternative is the one matched to your specific AHI severity, anatomy, BMI, and personal tolerance, confirmed by objective testing and tracked with biomarker monitoring over time.

Understanding what does not work is just as important as knowing what does. Several persistent myths about CPAP alternatives lead patients to make poorly informed decisions.

Comparing CPAP Alternatives: Which Option Fits Your Situation

Choosing between alternatives requires understanding how they compare across the dimensions that matter most: effectiveness, invasiveness, and who they work best for. The following structured comparison covers the most established CPAP alternatives side by side.

Effectiveness at Reducing AHI

• Oral Appliance Therapy (MAD): Reduces AHI by approximately 50% on average; best for mild to moderate obstructive sleep apnea
• Hypoglossal Nerve Stimulation (Inspire): Median 79% AHI reduction at five years in the STAR trial; effective for moderate to severe obstructive sleep apnea
• Uvulopalatopharyngoplasty (UPPP): Achieves AHI below 20 in roughly 40% to 50% of patients as a standalone procedure
• Maxillomandibular Advancement: Success rates exceeding 85% for reducing AHI below 15 in selected patients
• Positional Therapy: Effective only for position-dependent cases; reduces overall AHI to lateral-position levels
• Weight Loss (10% body weight): Reduces AHI by approximately 26% to 30% per NHLBI data
• GLP-1 Medications (Zepbound): Approximately 50% mean AHI reduction in obese patients in clinical trials

Invasiveness

• Oral Appliance Therapy (MAD): Non-invasive; custom dental device worn nightly
• Hypoglossal Nerve Stimulation (Inspire): Surgical implant under general anesthesia; outpatient surgery
• UPPP: Surgical; general anesthesia; significant recovery pain
• Maxillomandibular Advancement: Major surgery; inpatient hospital stay; weeks of recovery
• Positional Therapy: Non-invasive; wearable device or behavioral technique
• Weight Loss: Non-invasive but requires sustained effort
• GLP-1 Medications: Weekly injection; ongoing use required

Best For

• Oral Appliance Therapy (MAD): Mild to moderate OSA; patients who want a portable, non-machine option
• Hypoglossal Nerve Stimulation (Inspire): Moderate to severe OSA; patients who failed CPAP and meet anatomical criteria
• UPPP: Patients with identifiable soft palate obstruction; often combined with other procedures
• Maxillomandibular Advancement: Severe OSA with jaw anatomy contributing to obstruction
• Positional Therapy: Mild to moderate positional OSA; supplement to other treatments
• Weight Loss: Overweight and obese patients; addresses root cause
• GLP-1 Medications: Obese patients with moderate to severe OSA; prefer pharmaceutical over surgical approach

For most patients with mild to moderate obstructive sleep apnea who cannot tolerate CPAP, oral appliance therapy offers the best balance of effectiveness and convenience. For moderate to severe cases, Inspire Therapy provides the strongest clinical evidence among surgical options. Weight loss, whether through lifestyle modifications, bariatric surgery, or GLP-1 medications, should be pursued alongside any alternative for patients whose BMI contributes to their airway obstruction.

Regardless of which alternative you choose, confirming your starting AHI and tracking your biological response to treatment are both essential. Dumbo Health's biomarker testing offerings give you a way to measure not just whether your AHI is improving, but whether the downstream effects on inflammation, metabolism, and cardiovascular markers are reversing as well.

KEY TAKEAWAY: No CPAP alternative dominates across all dimensions; oral appliances win for mild to moderate convenience, Inspire wins for moderate to severe efficacy, and weight loss should be pursued in parallel whenever obesity is a contributing factor.

With comparisons clarified, it helps to separate evidence-based facts from the myths that often confuse patients evaluating their options.

Common Myths About CPAP Alternatives and Sleep Apnea Treatment Debunked

MYTH: Oral appliances work just as well as CPAP for all severities of sleep apnea.

FACT: Oral appliances are most effective for mild to moderate obstructive sleep apnea. The American Academy of Sleep Medicine specifically recommends CPAP over oral appliances for severe cases because MADs typically cannot reduce AHI enough when baseline obstruction is high. For mild to moderate cases, real-world outcomes between oral appliances and CPAP are often comparable because oral appliance adherence is higher, but this does not extend to severe sleep apnea.

MYTH: If you lose weight, your sleep apnea will definitely go away completely.

FACT: Weight loss significantly improves obstructive sleep apnea in overweight and obese patients, and the National Heart, Lung, and Blood Institute estimates a 10% weight reduction can decrease AHI by 26% to 30%. However, many patients retain residual apnea after weight loss because anatomical factors such as jaw structure, tongue size, and soft palate length also contribute independently. Weight loss is best understood as one component of a treatment plan, not a guaranteed cure.

MYTH: You do not need to follow up after starting a CPAP alternative because you will know if it is working by how you feel.

FACT: Subjective symptom improvement does not reliably predict AHI normalization. Patients often report feeling better while their Apnea-Hypopnea Index remains elevated enough to cause ongoing cardiovascular risk and metabolic damage. A follow-up sleep study or home sleep apnea test is essential to objectively verify that your chosen treatment is reducing apnea events to a safe level. Biomarker monitoring through a program like Dumbo Health adds another layer of verification by tracking whether inflammation and metabolic markers are actually improving.

MYTH: Inspire (hypoglossal nerve stimulation) is a quick, easy outpatient procedure with no significant recovery.

FACT: While Inspire implantation is performed as outpatient surgery, it involves general anesthesia, three incisions, and implantation of a generator, sensing lead, and stimulation lead. Recovery typically takes one to two weeks, and the device requires activation and titration over several follow-up visits. Battery replacement surgery is needed every 10 to 15 years. It is a legitimate surgical procedure, not a minor intervention.

MYTH: CPAP is the only treatment that actually reduces the health risks of sleep apnea.

FACT: Multiple treatments have been shown to reduce AHI and improve health outcomes. Oral appliances, hypoglossal nerve stimulation, weight loss, and properly targeted upper airway surgery can all meaningfully reduce apnea events and their associated cardiovascular and metabolic risks. The goal of any sleep apnea treatment is to reduce the Apnea-Hypopnea Index and oxygen desaturation index to levels that do not cause chronic physiological harm. CPAP is one way to achieve this, but it is not the only way.

KEY TAKEAWAY: Many common beliefs about CPAP alternatives are either oversimplified or incorrect, and making treatment decisions based on myths rather than clinical evidence can leave dangerous sleep apnea undertreated or lead to unnecessary procedures.

With myths cleared up, the final question is how sleep apnea treatment connects to the broader goal of protecting long-term health.

Sleep Apnea Treatment and Biological Aging: Why the Alternative You Choose Matters for Longevity

Effective sleep apnea treatment does more than stop snoring and reduce daytime sleepiness. It directly affects the biomarkers that determine how fast your body ages.

Untreated obstructive sleep apnea creates a nightly cycle of airway obstruction, oxygen desaturation, and stress-hormone surges. According to the National Institute on Aging, chronic sleep disruption is associated with accelerated biological aging, and the mechanisms are measurable: elevated hs-CRP (a marker of systemic inflammation), increased HbA1c (indicating impaired glucose metabolism), elevated cortisol, reduced heart rate variability, and worsening cardiovascular risk markers like ApoB.

These are not abstract laboratory findings. They translate into real-world outcomes: increased risk of heart disease, type 2 diabetes, cognitive decline, brain fog, and premature death. The Oxygen desaturation index, which measures how frequently blood oxygen drops during sleep, is directly linked to oxidative stress and vascular damage.

This is the reasoning behind Dumbo Health's SleepLongevityAge metric. Rather than treating sleep apnea as an isolated clinical condition, Dumbo Health measures 51 sleep-longevity biomarkers (or 103 on the Concierge plan) to calculate how sleep is accelerating or slowing your biological age. The score is built from blood biomarkers drawn through the Quest Diagnostics network at more than 2,000 locations nationwide, combined with optional wearable data from Oura, Whoop, or Garmin, and reviewed by board-certified physicians.

Whichever CPAP alternative you choose, tracking these biomarkers before and after treatment gives you objective evidence of whether your treatment is working at the biological level, not just the AHI level. A patient whose AHI drops from 25 to 8 with an oral appliance but whose hs-CRP and cortisol remain elevated may need additional intervention. A patient whose AHI drops to 5 and whose inflammation markers normalize is demonstrably reversing the aging effects of prior untreated sleep apnea.

The Core plan at $0.99 a day makes this level of monitoring accessible without insurance, with HSA and FSA eligibility and no prior authorization. For those who want comprehensive coverage including a dedicated sleep physician with 24/7 access and a personal sleep coach, the Concierge plan provides 103 biomarkers and all add-on specialty packs at $300 a month for early members.

Sleep apnea treatment is a longevity intervention. The alternative you choose should be evaluated not only by how well it opens your airway, but by how effectively it reverses the systemic damage that untreated apnea has already caused.

KEY TAKEAWAY: The best alternative to CPAP is not just the one that reduces your AHI, but the one that also reverses the inflammation, metabolic disruption, and cardiovascular strain that accelerate biological aging, which is why biomarker tracking alongside treatment is essential.

Conclusion

The best alternative to CPAP depends on your specific AHI severity, anatomy, BMI, and why CPAP did not work for you. Oral appliance therapy, hypoglossal nerve stimulation, upper airway surgery, positional therapy, weight management, and emerging pharmaceutical options each address different aspects of obstructive sleep apnea. No single alternative replaces CPAP for every patient, but for many people, an evidence-based alternative combined with biomarker monitoring delivers better real-world outcomes than an abandoned CPAP machine.

Whatever treatment path you choose, tracking whether it is actually reversing the biological aging effects of sleep apnea is the step most people skip. Take the free Dumbo Health quiz to understand your risk profile, or start with the $149 at-home sleep apnea test (Florida, Texas, Virginia and Maryland) to get an accurate AHI diagnosis with no insurance required and physician review typically within 48 hours.

Frequently Asked Questions About the Best Alternatives to CPAP

What is the best alternative to a CPAP machine?

The best alternative to CPAP depends on your sleep apnea severity, anatomy, lifestyle, and tolerance for different therapies. Oral appliance therapy using a mandibular advancement device is one of the most widely used and clinically supported CPAP alternatives for mild to moderate obstructive sleep apnea. Hypoglossal nerve stimulation, such as Inspire therapy, is an option for appropriately selected patients with moderate to severe OSA who cannot tolerate CPAP. Positional therapy, myofunctional therapy, weight loss, and upper airway surgery are additional pathways. A sleep specialist can help determine which option suits your individual case after reviewing your sleep study results and airway anatomy.

Why do some people look for alternatives to CPAP therapy?

Many people find CPAP therapy difficult to maintain long-term. Common reasons include mask discomfort, air pressure intolerance, noise, mask leaks, nasal congestion, and the disruption of the nightly routine. The American Academy of Sleep Medicine recognises that CPAP adherence is a significant clinical challenge, with many patients using the device fewer hours per night than recommended. When CPAP therapy is not tolerated, leaving sleep apnea untreated carries real health risks including cardiovascular strain, daytime sleepiness, and cognitive effects such as brain fog. Exploring alternatives is a reasonable and medically supported step when CPAP cannot be sustained.

Can you treat sleep apnea without CPAP?

Yes, sleep apnea can often be treated without CPAP, though the right approach depends on the type and severity of your condition. For obstructive sleep apnea, medically validated non-CPAP options include oral appliance therapy, hypoglossal nerve stimulation, upper airway surgery, positional therapy, and myofunctional therapy. Significant weight loss has also been shown to reduce apnea severity in patients with obesity-related OSA. Central sleep apnea is more complex and typically requires different management, including bilevel positive airway pressure or treatment of the underlying condition. A sleep specialist can assess which pathway is appropriate for your specific situation. Treating sleep apnea without medical supervision is not recommended.

What is oral appliance therapy and who is a good candidate?

Oral appliance therapy uses a custom-fitted dental device, most commonly a mandibular advancement device, worn during sleep to reposition the lower jaw and tongue forward, reducing airway obstruction. The American Academy of Sleep Medicine recommends oral appliance therapy as a first-line alternative to CPAP for adults with mild to moderate obstructive sleep apnea and as an option for patients with severe OSA who cannot tolerate CPAP. Good candidates typically have healthy teeth and gums, no significant jaw joint problems, and mild to moderate OSA confirmed by a sleep study. An otolaryngologist or qualified dental sleep medicine provider can assess suitability, and the device should be custom-fitted rather than an over-the-counter option.

Are mandibular advancement devices effective for sleep apnea?

Mandibular advancement devices, also called MADs, are clinically supported for reducing apnea-hypopnea index scores and improving sleep quality in patients with mild to moderate obstructive sleep apnea. They are generally less effective than CPAP at eliminating breathing events, but many patients tolerate and use them more consistently, which can make real-world outcomes comparable. Some patients with severe OSA also benefit when CPAP is not an option, though close monitoring is recommended. Effectiveness varies depending on jaw anatomy, tongue fat distribution, and the degree of airway obstruction. A sleep specialist or dental sleep provider should supervise fitting, titration, and follow-up to confirm treatment is working.

What is Inspire therapy and who is it for?

Inspire therapy is an implantable upper airway stimulation system that delivers gentle electrical impulses to the hypoglossal nerve during sleep, prompting the tongue and surrounding airway muscles to move forward and keep the airway open. It is approved by the Food and Drug Administration for adults with moderate to severe obstructive sleep apnea who have not responded adequately to CPAP. Inspire is activated by a small remote before sleep and does not involve a mask or air pressure. Clinical studies have shown Inspire therapy to be highly effective for appropriately selected patients. Ideal candidates typically have a body mass index below a specified threshold, confirmed OSA severity on a sleep study, and suitable airway anatomy verified through drug-induced sleep endoscopy.

What is Inspire V and what does it mean for patients?

Inspire V is a newer generation of the Inspire hypoglossal nerve stimulation system that includes updates to the implanted generator and sensing lead. It is designed to improve device longevity, sensing accuracy, and patient comfort. For patients, Inspire V means a potentially longer battery life and more refined airway stimulation compared to earlier versions of the device. The outpatient surgical procedure to implant the system remains similar. Patients considering Inspire therapy should discuss with their sleep specialist or otolaryngologist whether the current Inspire generation is appropriate for their anatomy and OSA severity.

What is the Genio system and how does it differ from Inspire?

The Genio system, developed by Nyxoah, is another hypoglossal nerve stimulation device used to treat obstructive sleep apnea. Unlike Inspire, which uses an implanted generator and sensing lead powered by a battery, the Genio system uses a small implanted neurostimulator chip near the chin that is activated by an external disposable patch worn during sleep. This design eliminates the need for an implanted battery, which may be relevant for patients who prefer to avoid a larger implanted generator. Availability, approval status, and clinical eligibility criteria differ by country and should be discussed with a qualified sleep medicine physician or otolaryngologist.

What is positional therapy for sleep apnea and how does it work?

Positional therapy is a treatment approach for patients whose obstructive sleep apnea is significantly worse when sleeping on their back, a pattern called positional or supine-dependent OSA. It works by encouraging side sleeping through wearable devices, vibrating sensors, or positional aids that prompt the sleeper to change position when they roll onto their back. The tennis ball technique, where a tennis ball is sewn into the back of a sleep shirt, is a low-cost version of this concept. Positional therapy is most appropriate for mild to moderate positional OSA and is less effective when apnea occurs in all sleep positions. A sleep study can confirm whether your OSA is position-dependent.

What is myofunctional therapy and can it help with sleep apnea?

Myofunctional therapy involves targeted exercises for the muscles of the tongue, mouth, and throat that support the upper airway. Regular practice aims to improve muscle tone in the soft palate, tongue, and lateral pharyngeal wall, which may reduce airway collapse during sleep. Research suggests myofunctional therapy can meaningfully reduce apnea-hypopnea index scores and snoring in some patients, and it is sometimes used alongside other treatments. It requires consistent daily commitment and works best in patients with mild to moderate OSA or as a complement to other therapies. A speech-language pathologist or myofunctional therapist trained in sleep disorders can guide a structured programme.

What surgical treatments exist for sleep apnea beyond CPAP?

Several surgical options exist for obstructive sleep apnea when CPAP and other conservative treatments are not effective or tolerated. Uvulopalatopharyngoplasty, or UPPP, removes excess tissue from the soft palate and throat to widen the airway. Barbed reposition pharyngoplasty and lateral pharyngoplasty are newer soft palate techniques that aim for better outcomes. Maxillomandibular advancement repositions the jaw bones to enlarge the airway structurally. Nasal surgery, including septoplasty and turbinate reduction, can improve nasal airflow and CPAP tolerance. Tonsillectomy and adenoidectomy are common in children. A drug-induced sleep endoscopy helps surgeons identify the precise site of airway obstruction before recommending a surgical approach. Surgical outcomes vary and carry their own risks, which should be discussed with an otolaryngologist or sleep surgeon.

What are EPAP devices and how do they work?

Expiratory positive airway pressure devices, or EPAP devices, are small valves worn at the nostrils that create resistance during exhalation. This resistance generates back-pressure that helps hold the airway open during the following breath. Nasal EPAP products such as Provent Therapy have been studied as a CPAP alternative for mild to moderate obstructive sleep apnea in patients who cannot tolerate a CPAP mask. They are more portable and simpler to use than CPAP machines. EPAP devices are not suitable for all OSA patients, and their effectiveness varies. A sleep specialist should confirm whether EPAP therapy is an appropriate match for your apnea severity and airway anatomy.

What is eXciteOSA and how does it treat sleep apnea?

eXciteOSA is a daytime electric muscle stimulation device worn on the tongue for approximately 20 minutes once a day while awake. It delivers low-level electrical pulses to improve tongue muscle tone, which may reduce the degree of tongue and airway collapse during sleep at night. It is designed as a non-invasive treatment for mild obstructive sleep apnea and snoring. The Food and Drug Administration has cleared eXciteOSA for prescription use. It is not a replacement for CPAP in moderate to severe sleep apnea, and clinical outcomes vary between patients. A sleep physician can advise whether this type of tongue stimulation device is appropriate for your situation.

Can weight loss or GLP-1 medications reduce sleep apnea severity?

Significant weight loss can reduce obstructive sleep apnea severity in patients where obesity is a contributing factor, since excess weight, including tongue fat, can narrow the airway during sleep. The Wisconsin Sleep Cohort Study and other research have established links between body mass index and OSA severity. Glucagon-like peptide-1 receptor agonists, such as Zepbound, have shown meaningful reductions in apnea-hypopnea index scores in clinical trials involving patients with obesity-related OSA. Bariatric surgery can also produce substantial improvements in some patients. However, weight loss does not eliminate sleep apnea in all cases, and a repeat sleep study should confirm whether treatment can be modified or discontinued. These decisions require clinician guidance and should not be made independently.

Are over-the-counter sleep apnea devices safe and effective?

Over-the-counter devices marketed for sleep apnea, including generic mouthguards and basic positional aids, vary considerably in quality and are not the same as clinically evaluated and custom-fitted devices. The American Academy of Sleep Medicine recommends custom-fitted oral appliances made by qualified dental sleep providers rather than generic options. Over-the-counter products have not typically been studied in the same rigorous clinical trials as prescription-grade mandibular advancement devices or FDA-cleared therapies. Using an unsupervised device without a confirmed diagnosis can delay appropriate treatment and allow sleep apnea to go undertreated. Anyone experiencing symptoms of sleep apnea should seek a proper sleep study and clinician review before relying on an over-the-counter product.

Are CPAP alternatives effective for severe sleep apnea?

CPAP alternatives can be effective for some patients with severe obstructive sleep apnea, but the evidence varies by treatment type and individual anatomy. Inspire hypoglossal nerve stimulation has demonstrated clinically meaningful reductions in apnea-hypopnea index scores in patients with moderate to severe OSA who meet eligibility criteria. Maxillomandibular advancement surgery has also shown strong outcomes in selected patients with structural airway obstruction. Oral appliances are less reliably effective in severe OSA but may still be appropriate when CPAP cannot be tolerated and other options are not suitable. Bilevel positive airway pressure, or BiPAP, is another pressure-based alternative for those who struggle with standard CPAP air pressure. A sleep specialist should guide treatment selection based on your apnea severity and overall health profile.

Can central sleep apnea be treated without CPAP?

Central sleep apnea differs from obstructive sleep apnea in that it is caused by a failure of the brain's breathing signal rather than physical airway obstruction, which means most mechanical and positional CPAP alternatives are not effective for it. Treatment typically focuses on the underlying cause, which may include heart failure, opioid use, or high-altitude exposure. Bilevel positive airway pressure with a backup rate, adaptive servo-ventilation, and targeted medications are more commonly used management options. Because central sleep apnea requires a different clinical approach, accurate diagnosis through a sleep study and physician evaluation is essential before any treatment decisions are made.

What if I cannot tolerate my CPAP machine?

CPAP intolerance is common and should be addressed rather than ignored, since untreated sleep apnea carries serious long-term health risks including cardiovascular disease and persistent daytime sleepiness. Common problems include mask discomfort, mask leaks, air pressure intolerance, nasal dryness, and difficulty exhaling against the pressure. Practical adjustments such as switching mask style, trying nasal pillows, adding a heated humidifier, or switching to an APAP machine that automatically adjusts air pressure can help some patients. If these adjustments are not sufficient, a sleep specialist can evaluate whether oral appliance therapy, positional therapy, or another medically validated alternative is appropriate. Abandoning treatment without clinical guidance is not recommended.

How much do CPAP alternatives cost and does insurance cover them?

Costs vary widely depending on the treatment. Custom oral appliances, Inspire surgery, and simpler devices like positional aids and EPAP products differ a lot in cost. Insurance coverage depends on your plan, your sleep apnea diagnosis, and whether the prescribed treatment meets your insurer's medical necessity criteria. Oral appliance therapy and Inspire therapy are often covered by insurance when a qualifying sleep study and physician referral are in place, though prior authorisation requirements vary. For those who prefer cash-pay sleep apnea testing with transparent pricing and no insurance required, Dumbo Health's at-home sleep apnea test is available for $149 as a first step toward a physician-reviewed diagnosis.

Is oral appliance therapy covered by insurance?

Oral appliance therapy for sleep apnea is covered by many health insurance plans when prescribed by a qualified clinician following a confirmed sleep apnea diagnosis, but coverage terms vary significantly between insurers. Medical insurance, rather than dental insurance, typically covers oral appliances when they are used to treat OSA. Prior authorisation is often required, and documentation including a sleep study report and physician prescription is usually needed. Patients paying out of pocket should ask for an itemised estimate before proceeding, as costs for custom-fitted mandibular advancement devices can be substantial. A sleep specialist or dental sleep provider can advise on the documentation process for insurance submission.

Can I travel with a CPAP alternative?

Yes, many CPAP alternatives are easier to travel with than a standard CPAP machine. Custom oral appliances are compact, require no power source, and pack easily in a carry-on bag. Nasal EPAP devices are single-use disposables and are similarly portable. Positional therapy wearables are lightweight. Inspire therapy is implanted, so it travels with you without any external equipment beyond a small remote. For frequent travellers who find CPAP machines inconvenient, oral appliance therapy or an Inspire device may offer a meaningful lifestyle advantage. Regardless of which alternative you use, maintaining consistent treatment while travelling is important for managing sleep apnea and its associated health risks.

Should I switch from CPAP to an alternative treatment?

Switching away from CPAP should be a decision made with a qualified sleep specialist rather than independently. If you are using CPAP effectively, switching carries some risk since most alternatives are less consistently effective at eliminating breathing events across all patients. However, if you are not using your CPAP device regularly due to intolerance, an alternative that you will actually use may provide better real-world outcomes. A sleep study, Epworth Sleepiness Scale assessment, and clinical review of your apnea-hypopnea index data can help your clinician determine whether a switch is medically appropriate. Never discontinue CPAP therapy without speaking to your sleep physician first.

Can sleep apnea be completely cured?

Sleep apnea cannot always be permanently cured, but some patients do achieve long-term resolution, particularly when a specific underlying cause is addressed. Significant and sustained weight loss can reduce or eliminate OSA in some patients with obesity-related apnea. Maxillomandibular advancement surgery produces durable results in appropriate candidates by permanently enlarging the airway. Children who undergo tonsillectomy and adenoidectomy for OSA may see complete resolution. For most adults, sleep apnea is a chronic condition that requires ongoing management rather than a one-time cure. A sleep specialist can assess whether your specific anatomy, weight, and apnea severity make complete resolution a realistic goal.

How do I choose among sleep apnea treatments other than CPAP?

Choosing a CPAP alternative starts with understanding your sleep apnea type, severity, and anatomy. A sleep study provides your apnea-hypopnea index and oxygen desaturation index, which inform treatment suitability. A drug-induced sleep endoscopy can identify the precise site of airway collapse, which is especially useful when surgery is being considered. Your lifestyle, travel habits, comfort priorities, willingness to commit to exercises such as myofunctional therapy, and tolerance for procedures all factor into the decision. A sleep medicine specialist or otolaryngologist can map these factors to the most appropriate options. The Dumbo Health sleep and longevity assessment can be a useful starting point if you are also interested in understanding how your sleep may be affecting your broader health.

How does a home sleep apnea test support getting access to CPAP alternatives?

A home sleep apnea test, also called an HSAT, provides the diagnostic foundation needed for most CPAP alternative pathways. Oral appliance prescriptions, Inspire therapy evaluation, and insurance coverage for most treatments all require a confirmed OSA diagnosis, which a sleep study provides. An at-home sleep test measures breathing events, oxygen saturation, and airflow during a normal night of sleep at home, without the need for an overnight clinic visit. Results are reviewed by a physician who can confirm a diagnosis and recommend an appropriate treatment pathway. According to the American Academy of Sleep Medicine, home sleep testing is appropriate for adults with a high pre-test probability of moderate to severe obstructive sleep apnea. Dumbo Health offers a $149 at-home sleep apnea test with physician diagnosis typically within 48 hours, available with cash-pay pricing and no insurance required.

How does biomarker testing connect to sleep apnea and overall health?

Sleep apnea is associated with a range of systemic health effects, including elevated inflammatory markers, metabolic disruption, cardiovascular strain, and hormonal changes. Biomarker panels that measure markers such as hs-CRP, HbA1c, cortisol, testosterone, and ApoB can reveal how untreated or undertreated sleep apnea may be affecting biological health over time. According to the National Heart, Lung, and Blood Institute, obstructive sleep apnea is linked to high blood pressure, heart disease, and metabolic conditions. Dumbo Health's sleep longevity membership includes biomarker testing twice a year, a SleepLongevityAge score, and physician interpretation to help members understand how their sleep is influencing biological aging. A physician can help interpret what specific results mean for your individual health.

What is SleepLongevityAge and how does it relate to sleep apnea?

SleepLongevityAge is a proprietary metric from Dumbo Health that reflects how sleep may be accelerating or slowing biological aging, calculated from blood biomarker data and optional wearable information from devices such as Oura, Whoop, or Garmin. Untreated sleep apnea is one of the patterns that can push biological markers in a direction associated with faster aging, including elevated inflammation, cortisol dysregulation, and cardiovascular strain. By tracking SleepLongevityAge over time, members can see whether sleep improvements, including treatment of sleep apnea, are reflected in their biomarker profile. A SleepLongevityAge score is a wellness and screening metric, not a clinical diagnosis. Abnormal results should always be reviewed with a qualified healthcare professional. Learn more about the sleep longevity programme at Dumbo Health.

Do commercial drivers need to address sleep apnea even if they feel fine?

Yes. Commercial drivers with untreated obstructive sleep apnea face safety risks on the road related to daytime sleepiness and impaired reaction time, even when they do not perceive themselves as significantly impaired. The FMCSA and certified medical examiners consider sleep apnea risk factors including neck circumference, body mass index, blood pressure, and reported symptoms when evaluating drivers for DOT medical certification. A certified medical examiner, not Dumbo Health, makes DOT certification decisions. However, completing an at-home sleep apnea test and pursuing treatment documentation can support a driver's ability to demonstrate compliance and manage their health proactively. Dumbo Health can support sleep apnea testing for CDL drivers with transparent, cash-pay pricing and physician-reviewed results.

Where can I find sleep apnea testing or blood draw locations near me?

For at-home sleep apnea testing, you can complete a one-night test at home using an FDA-cleared device, which removes the need to travel to a sleep lab. For biomarker blood panels, Dumbo Health works with a lab network that includes testing locations across the United States. You can find blood draw and testing locations near you through the Dumbo Health testing locations page. A healthcare professional can also direct you to appropriate diagnostic facilities in your area depending on whether you need a home sleep test, an in-lab polysomnography study, or a specialised sleep medicine evaluation.